 |
The Journal of Neuroscience, September 28, 2005, 25(39):9027-9036; doi:10.1523/JNEUROSCI.2567-05.2005
Previous Article | Next Article 
Cellular/Molecular
Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors
Rongsheng Jin,1
Suzanne Clark,4
Autumn M. Weeks,4
Joshua T. Dudman,2
Eric Gouaux,1,3 and
Kathryn M. Partin4
1Department of Biochemistry and Molecular Biophysics, 2Center for Neurobiology and Behavior, and 3Howard Hughes Medical Institute, Columbia University, New York, New York 10032, and 4Department of Biomedical Sciences, Division of Neuroscience, Colorado State University, Fort Collins, Colorado 80523
Ligand-gated ion channels involved in the modulation of synaptic strength are the AMPA, kainate, and NMDA glutamate receptors. Small molecules that potentiate AMPA receptor currents relieve cognitive deficits caused by neurodegenerative diseases such as Alzheimer's disease and show promise in the treatment of depression. Previously, there has been limited understanding of the molecular mechanism of action for AMPA receptor potentiators. Here we present cocrystal structures of the glutamate receptor GluR2 S1S2 ligand-binding domain in complex with aniracetam [1-(4-methoxybenzoyl)-2-pyrrolidinone] or CX614 (pyrrolidino-1,3-oxazino benzo-1,4-dioxan-10-one), two AMPA receptor potentiators that preferentially slow AMPA receptor deactivation. Both potentiators bind within the dimer interface of the nondesensitized receptor at a common site located on the twofold axis of molecular symmetry. Importantly, the potentiator binding site is adjacent to the "hinge" in the ligand-binding core "clamshell" that undergoes conformational rearrangement after glutamate binding. Using rapid solution exchange, patch-clamp electrophysiology experiments, we show that point mutations of residues that interact with potentiators in the cocrystal disrupt potentiator function. We suggest that the potentiators slow deactivation by stabilizing the clamshell in its closed-cleft, glutamate-bound conformation.
Key words: glutamate receptor; desensitization; deactivation; kinetics; crystallography; cyclothiazide; aniracetam; CX614
Received June 22, 2005;
revised August 12, 2005;
accepted August 16, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
K. E. Montgomery, M. Kessler, and A. C. Arai
Modulation of Agonist Binding to AMPA Receptors by 1-(1,4-Benzodioxan-6-ylcarbonyl)piperidine (CX546): Differential Effects across Brain Regions and GluA1-4/Transmembrane AMPA Receptor Regulatory Protein Combinations
J. Pharmacol. Exp. Ther.,
December 1, 2009;
331(3):
965 - 974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yuan, K. B. Hansen, K. M. Vance, K. K. Ogden, and S. F. Traynelis
Control of NMDA Receptor Function by the NR2 Subunit Amino-Terminal Domain
J. Neurosci.,
September 30, 2009;
29(39):
12045 - 12058.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Berezhnoy, T. T. Gibbs, and D. H. Farb
Docking of 1,4-Benzodiazepines in the {alpha}1/{gamma}2 GABAA Receptor Modulator Site
Mol. Pharmacol.,
August 1, 2009;
76(2):
440 - 450.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Chaudhry, A. J. R. Plested, P. Schuck, and M. L. Mayer
Energetics of glutamate receptor ligand binding domain dimer assembly are modulated by allosteric ions
PNAS,
July 28, 2009;
106(30):
12329 - 12334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Schmid, S. Kott, C. Sager, T. Huelsken, and M. Hollmann
The glutamate receptor subunit delta2 is capable of gating its intrinsic ion channel as revealed by ligand binding domain transplantation
PNAS,
June 23, 2009;
106(25):
10320 - 10325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Hansen, P. Naur, N. L. Kurtkaya, A. S. Kristensen, M. Gajhede, J. S. Kastrup, and S. F. Traynelis
Modulation of the Dimer Interface at Ionotropic Glutamate-Like Receptor {delta}2 by D-Serine and Extracellular Calcium
J. Neurosci.,
January 28, 2009;
29(4):
907 - 917.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang, Y. Cho, E. Lolis, and J. R. Howe
Structural and Single-Channel Results Indicate That the Rates of Ligand Binding Domain Closing and Opening Directly Impact AMPA Receptor Gating
J. Neurosci.,
January 23, 2008;
28(4):
932 - 943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Ahmed, A. P. Loh, D. E. Jane, and R. E. Oswald
Dynamics of the S1S2 Glutamate Binding Domain of GluR2 Measured Using 19F NMR Spectroscopy
J. Biol. Chem.,
April 27, 2007;
282(17):
12773 - 12784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, N. Nayeem, M. H. Nanao, and T. Green
Interface Interactions Modulating Desensitization of the Kainate-Selective Ionotropic Glutamate Receptor Subunit GluR6
J. Neurosci.,
September 27, 2006;
26(39):
10033 - 10042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Bedoukian, A. M. Weeks, and K. M. Partin
Different Domains of the AMPA Receptor Direct Stargazin-mediated Trafficking and Stargazin-mediated Modulation of Kinetics
J. Biol. Chem.,
August 18, 2006;
281(33):
23908 - 23921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tomita, M. Sekiguchi, K. Wada, R. A. Nicoll, and D. S. Bredt
Stargazin controls the pharmacology of AMPA receptor potentiators
PNAS,
June 27, 2006;
103(26):
10064 - 10067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Mayer, A. Ghosal, N. P. Dolman, and D. E. Jane
Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists.
J. Neurosci.,
March 15, 2006;
26(11):
2852 - 2861.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|